Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies.
Amedica will assist Spinal Kinetics with their proprietary design, development, manufacture and supply of silicon nitride spinal implants. The agreement underscores Amedica’s continued focus to provide superior and innovative solutions to the market.
“We are very pleased to announce an additional element to this growing alliance with Spinal Kinetics,” said Dr. Sonny Bal, Chairman and CEO of Amedica Corporation. “We remain committed to offering our customers a biomaterial that contains distinct benefits to improve the efficacy of spinal fusion procedures, resulting in enhanced patient care. I am convinced that this, and other similar agreements, will lead to faster and more widespread market penetration of silicon nitride, positioning it as the biomaterial of choice for medical applications.”
Silicon nitride is a unique biomaterial that can be shaped and engineered into complex designs and surfaces to address a variety of medical needs. Unlike other leading biomaterials in the market today, silicon nitride contains anti-bacterial properties and also supports rapid bone on-growth and in-growth. This combination of optimal material properties is unique to Amedica’s silicon nitride material platform.
“This agreement further expands our use of Amedica’s silicon nitride technology platform and will now allow us to take this biomaterial directly to our customers and develop it according to their specifications,” said Tom Afzal, President and CEO of Spinal Kinetics. “This novel biomaterial will provide Spinal Kinetics the opportunity to continue to provide unique spinal implants as we continue to expand our technology platform.”